Sebetralstat: a paradigm shift in hereditary angioedema management. [PDF]
Qadri M, Iqbal MU, Hajj F.
europepmc +1 more source
A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee. [PDF]
Cancian M +10 more
europepmc +1 more source
Lanadelumab in Hereditary Angioedema: Extending Dose Intervals from Every 2 Weeks to Every 4 Weeks.
Riedl MA +6 more
europepmc +1 more source
Concurrent hereditary angioedema type I and common variable immunodeficiency presenting as suspected antibiotic hypersensitivity: Case report and literature discussion. [PDF]
Urdea D +3 more
europepmc +1 more source
Global research trends in hereditary angioedema, 1972-2023: Bibliometric analysis of productivity, collaboration, and thematic evolution. [PDF]
Mak HWF +5 more
europepmc +1 more source
Association Between the Angioedema Control Test and Attack Frequency in Hereditary Angioedema. [PDF]
Yarlas A +7 more
europepmc +1 more source
Lanadelumab safety, efficacy, and pharmacokinetics in patients aged ≥12 with hereditary angioedema in China: an open-label, multicenter study. [PDF]
Zhi Y +6 more
europepmc +1 more source
Related searches:
Hereditary angioedema (HAE) is a rare autosomal dominant genetic disorder that usual results from a decreased level of functional C1-INH and clinically manifests with intermittent attacks of swelling of the subcutaneous tissue or submucosal layers of the respiratory or gastrointestinal tracts.
R Gentry, Wilkerson, Joseph J, Moellman
openaire +3 more sources
Hereditary Angioedema in Pregnancy
Obstetrical & Gynecological Survey, 2021Importance Hereditary angioedema is a rare disease of potentially life-threatening attacks of angioedema that can affect patients of all ages, including women of childbearing age. Pregnancy can affect the course of the disease and the choice of treatment used. It is important for the care providers to recognize this disease and
Irene I, Chair +2 more
openaire +2 more sources

